Molecular Diagnostics Market Size, Share, and Trends Analysis 2032
Molecular Diagnostics Market By Product & Services (Reagents and Kits, Instruments, and Software and Services), By Application (Genetic Tests, Infectious Diseases, Oncology, and Others), By Technology (PCR, INAAT, DNA Sequencing & NGS, In Situ Hybridization, DNA Microarrays, and Others), By End-User (Diagnostic Laboratories, Hospitals, and Others), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 16.27 Billion | USD 44.03 Billion | 11.7% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global molecular diagnostics market, 2024-2032 (USD Billion)
- 2.2. Global molecular diagnostics market: Snapshot
- Chapter 3. Molecular Diagnostics Market - Industry Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global molecular diagnostics market drivers: Impact analysis
- 3.2.2. High Prevalence of Infectious Diseases and Various Types of Cancers
- 3.2.3. Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
- 3.2.4. Growth in the Biomarker Identification Market and Advancements in Molecular Techniques
- 3.3. Market Restraints
- 3.3.1. Global molecular diagnostics market restraints: Impact analysis
- 3.3.2. Complex Regulatory Frameworks Delaying the Approval of New Molecular Diagnostic Tests
- 3.3.3. The dearth of Trained Professionals Limiting the Appropriate Use of New Molecular Diagnostic Technologies
- 3.4. Opportunities
- 3.4.1. Advances in Genomics and Proteomics
- 3.4.2. Growth Opportunities in Emerging Markets
- 3.5. Porter's Five Forces Analysis
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by product and services
- 3.6.2. Market attractiveness analysis, by application
- 3.6.3. Market attractiveness analysis, by technology
- 3.6.4. Market attractiveness analysis, by end-user
- 3.6.5. Market attractiveness analysis, by region
- Chapter 4. Global Molecular Diagnostics Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global molecular diagnostics market: company market share, 2024
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New instruments launch
- 4.2.3. Agreements, partnerships, collaborations, and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.1. Company market share analysis
- Chapter 5. Global Molecular Diagnostics Market - Product and Services Analysis
- 5.1. Global molecular diagnostics market: Product and Services overview
- 5.1.1. Global molecular diagnostics market revenue share, by products and services, 2024 and 2032
- 5.2. Reagents and Kits
- 5.2.1. Global molecular diagnostics market for reagents and kits, 2024-2032 (USD Billion)
- 5.3. Instruments
- 5.3.1. Global molecular diagnostics market for instruments, 2024-2032 (USD Billion)
- 5.4. Software and Services
- 5.4.1. Global molecular diagnostics market for software and services, 2024-2032 (USD Billion)
- 5.1. Global molecular diagnostics market: Product and Services overview
- Chapter 6. Global Molecular Diagnostics Market - Application Analysis
- 6.1. Global molecular diagnostics market: Application overview
- 6.1.1. Global molecular diagnostics market revenue share, by application, 2024 and 2032
- 6.2. Genetic Tests
- 6.2.1. Global molecular diagnostics market for genetic tests, 2024-2032 (USD Billion)
- 6.3. Infectious Diseases
- 6.3.1. Global molecular diagnostics market for infectious diseases, 2024-2032 (USD Billion)
- 6.4. Oncology
- 6.4.1. Global molecular diagnostics market for oncology, 2024-2032 (USD Billion)
- 6.5. Others
- 6.5.1. Global molecular diagnostics market for others, 2024-2032 (USD Billion)
- 6.1. Global molecular diagnostics market: Application overview
- Chapter 7. Global Molecular Diagnostics Market - Technology Analysis
- 7.1. Global molecular diagnostics market: Technology overview
- 7.1.1. Global molecular diagnostics market revenue share, by technology, 2024 and 2032
- 7.2. PCR
- 7.2.1. Global molecular diagnostics market for PCR, 2024-2032 (USD Billion)
- 7.3. INAAT
- 7.3.1. Global molecular diagnostics market for INAAT, 2024-2032 (USD Billion)
- 7.4. DNA sequencing and NGS
- 7.4.1. Global molecular diagnostics market for DNA sequencing and NGS, 2024-2032 (USD Billion)
- 7.5. In Situ Hybridization
- 7.5.1. Global molecular diagnostics market for in situ hybridization, 2024-2032 (USD Billion)
- 7.6. DNA microarrays
- 7.6.1. Global molecular diagnostics market for DNA microarrays, 2024-2032 (USD Billion)
- 7.7. Others
- 7.7.1. Global molecular diagnostics market for others, 2024-2032 (USD Billion)
- 7.1. Global molecular diagnostics market: Technology overview
- Chapter 8. Global Molecular Diagnostics Market - End-User Analysis
- 8.1. Global molecular diagnostics market: End-User overview
- 8.1.1. Global molecular diagnostics market revenue share, by End-User, 2024 and 2032
- 8.2. Diagnostic Laboratories
- 8.2.1. Global molecular diagnostics market for diagnostic laboratories, 2024-2032 (USD Billion)
- 8.3. Hospitals
- 8.3.1. Global molecular diagnostics market for hospitals, 2024-2032 (USD Billion)
- 8.4. Others
- 8.4.1. Global molecular diagnostics market for others, 2024-2032 (USD Billion)
- 8.1. Global molecular diagnostics market: End-User overview
- Chapter 9. Global Molecular Diagnostics Market - Regional Analysis
- 9.1. Global molecular diagnostics market: Regional overview
- 9.1.1. Global molecular diagnostics market revenue share, by region, 2024 and 2032
- 9.2. North America
- 9.2.1. North America molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.2.2. North America molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.2.3. North America molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.2.4. North America molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.2.5. The U.S.
- 9.2.5.1. The U.S. molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.2.5.2. The U.S. molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.2.5.3. The U.S. molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.2.5.4. The U.S. molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.2.6. Canada
- 9.2.6.1. Canada molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.2.6.2. Canada molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.2.6.3. Canada molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.2.6.4. Canada molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.3. Europe
- 9.3.1. Europe molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.3.2. Europe molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.3.3. Europe molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.3.4. Europe molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.3.5. UK
- 9.3.5.1. UK molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.3.5.2. UK molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.3.5.3. UK molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.3.5.4. UK molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.3.6. Germany
- 9.3.6.1. Germany molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.3.6.2. Germany molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.3.6.3. Germany molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.3.6.4. Germany molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.3.7. France
- 9.3.7.1. France molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.3.7.2. France molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.3.7.3. France molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.3.7.4. France molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.3.8. Rest of Europe
- 9.3.8.1. Rest of Europe molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.3.8.2. Rest of Europe molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.3.8.3. Rest of Europe molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.3.8.4. Rest of Europe molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.4. Asia Pacific
- 9.4.1. Asia Pacific molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.4.2. Asia Pacific molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.4.3. Asia Pacific molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.4.4. Asia Pacific molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.4.5. China
- 9.4.5.1. China molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.4.5.2. China molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.4.5.3. China molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.4.5.4. China molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.4.6. Japan
- 9.4.6.1. Japan molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.4.6.2. Japan molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.4.6.3. Japan molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.4.6.4. Japan molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.4.7. India
- 9.4.7.1. India molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.4.7.2. India molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.4.7.3. India molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.4.7.4. India molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.4.8. Rest of Asia Pacific
- 9.4.8.1. Rest of Asia Pacific molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.4.8.2. Rest of Asia Pacific molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.4.8.3. Rest of Asia Pacific molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.4.8.4. Rest of Asia Pacific molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.5. Latin America
- 9.5.1. Latin America molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.5.2. Latin America molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.5.3. Latin America molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.5.4. Latin America molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.5.5. Brazil
- 9.5.5.1. Brazil molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.5.5.2. Brazil molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.5.5.3. Brazil molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.5.5.4. Brazil molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.5.6. Rest of Latin America
- 9.5.6.1. Rest of Latin America molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.5.6.2. Rest of Latin America molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.5.6.3. Rest of Latin America molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.5.6.4. Rest of Latin America molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.6. The Middle East and Africa
- 9.6.1. The Middle East and Africa molecular diagnostics market revenue, by product and services, 2024-2032 (USD Billion)
- 9.6.2. The Middle East and Africa molecular diagnostics market revenue, by application, 2024-2032 (USD Billion)
- 9.6.3. The Middle East and Africa molecular diagnostics market revenue, by technology, 2024-2032 (USD Billion)
- 9.6.4. The Middle East and Africa molecular diagnostics market revenue, by End-User, 2024-2032 (USD Billion)
- 9.1. Global molecular diagnostics market: Regional overview
- Chapter 10. Company Profile
- 10.1. Becton Dickinson
- 10.1.1. Overview
- 10.1.2. Financials
- 10.1.3. Product Portfolio
- 10.1.4. Business Strategy
- 10.1.5. Recent Developments
- 10.2. Abbott Laboratories
- 10.2.1. Overview
- 10.2.2. Financials
- 10.2.3. Product Portfolio
- 10.2.4. Business Strategy
- 10.2.5. Recent Developments
- 10.3. Roche Diagnostics
- 10.3.1. Overview
- 10.3.2. Financials
- 10.3.3. Product Portfolio
- 10.3.4. Business Strategy
- 10.3.5. Recent Developments
- 10.4. Novartis
- 10.4.1. Overview
- 10.4.2. Financials
- 10.4.3. Product Portfolio
- 10.4.4. Business Strategy
- 10.4.5. Recent Developments
- 10.5. Johnson and Johnson
- 10.5.1. Overview
- 10.5.2. Financials
- 10.5.3. Product Portfolio
- 10.5.4. Business Strategy
- 10.5.5. Recent Developments
- 10.6. bioMerieux
- 10.6.1. Overview
- 10.6.2. Financials
- 10.6.3. Product Portfolio
- 10.6.4. Business Strategy
- 10.6.5. Recent Developments
- 10.7. Bio-Rad Laboratories
- 10.7.1. Overview
- 10.7.2. Financials
- 10.7.3. Product Portfolio
- 10.7.4. Business Strategy
- 10.7.5. Recent Developments
- 10.8. Qiagen NV
- 10.8.1. Overview
- 10.8.2. Financials
- 10.8.3. Product Portfolio
- 10.8.4. Business Strategy
- 10.8.5. Recent Developments
- 10.9. Danaher Corporation
- 10.9.1. Overview
- 10.9.2. Financials
- 10.9.3. Product Portfolio
- 10.9.4. Business Strategy
- 10.9.5. Recent Developments
- 10.10. Siemens Healthcare
- 10.10.1. Overview
- 10.10.2. Financials
- 10.10.3. Product Portfolio
- 10.10.4. Business Strategy
- 10.10.5. Recent Developments
- 10.11. Hologic
- 10.11.1. Overview
- 10.11.2. Financials
- 10.11.3. Product Portfolio
- 10.11.4. Business Strategy
- 10.11.5. Recent Developments
- 10.1. Becton Dickinson
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global molecular diagnostics market revenue, 2024–2032 (USD Billion)
4. Porter’s Five Forces Analysis
5. Molecular Diagnostics market attractiveness analysis, by product and services
6. Molecular Diagnostics market attractiveness analysis, by application
7. Molecular Diagnostics market attractiveness analysis, by technology
8. Molecular Diagnostics market attractiveness analysis, by End-User
9. Molecular Diagnostics market: market attractiveness analysis, by region
10. Company market share analysis, 2024
11. Global molecular diagnostics market revenue share by product and services, 2024 and 2032
12. Global molecular diagnostics market for reagents and kits, 2024–2032 (USD Billion)
13. Global molecular diagnostics market for instruments, 2024–2032 (USD Billion)
14. Global molecular diagnostics market for software and services, 2024–2032 (USD Billion)
15. Global molecular diagnostics market revenue share by application, 2024 and 2032
16. Global molecular diagnostics market for genetic tests, 2024–2032 (USD Billion)
17. Global molecular diagnostics market for infectious disease, 2024–2032 (USD Billion)
18. Global molecular diagnostics market for oncology, 2024–2032 (USD Billion)
19. Global molecular diagnostics market for others, 2024–2032 (USD Billion)
20. Global molecular diagnostics market revenue share by technology, 2024 and 2032
21. Global molecular diagnostics market for PCR, 2024–2032 (USD Billion)
22. Global molecular diagnostics market for INAAT, 2024–2032 (USD Billion)
23. Global molecular diagnostics market for DNA sequencing and NGS, 2024–2032 (USD Billion)
24. Global molecular diagnostics market for in situ hybridization, 2024–2032 (USD Billion)
25. Global molecular diagnostics market for DNA microarrays, 2024–2032 (USD Billion)
26. Global molecular diagnostics market for others, 2024–2032 (USD Billion)
27. Global molecular diagnostics market revenue share by End-User, 2024 and 2032
28. Global molecular diagnostics market for diagnostic laboratories, 2024–2032 (USD Billion)
29. Global molecular diagnostics market for hospitals, 2024–2032 (USD Billion)
30. Global molecular diagnostics market for others, 2024–2032 (USD Billion)
31. North America molecular diagnostics market, 2024–2032 (USD Billion)
32. Europe molecular diagnostics market, 2024–2032 (USD Billion)
33. Asia Pacific molecular diagnostics market, 2024–2032 (USD Billion)
34. Latin America molecular diagnostics market, 2024–2032 (USD Billion)
35. The Middle East and Africa molecular diagnostics market, 2024–2032 (USD Billion)
Table Of Tables
List of Tables
1. Global molecular diagnostics market: Market Snapshot
2. Drivers of the global molecular diagnostics market: Impact analysis
3. Restraints of the global molecular diagnostics market: Impact analysis
4. North America molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
5. North America molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
6. North America molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
7. North America molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
8. The U.S. molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
9. The U.S. molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
10. The U.S. molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
11. The U.S. molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
12. Canada molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
13. Canada molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
14. Canada molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
15. Canada molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
16. Europe molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
17. Europe molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
18. Europe molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
19. Europe molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
20. UK molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
21. UK molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
22. UK molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
23. UK molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
24. Germany molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
25. Germany molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
26. Germany molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
27. Germany molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
28. France molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
29. France molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
30. France molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
31. France molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
32. Rest of Europe molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
33. Rest of Europe molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
34. Rest of Europe molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
35. Rest of Europe molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
36. Asia Pacific molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
37. Asia Pacific molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
38. Asia Pacific molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
39. Asia Pacific molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
40. China molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
41. China molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
42. China molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
43. China molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
44. Japan molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
45. Japan molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
46. Japan molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
47. Japan molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
48. India molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
49. India molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
50. India molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
51. India molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
52. Rest of Asia Pacific molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
53. Rest of Asia Pacific molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
54. Rest of Asia Pacific molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
55. Rest of Asia Pacific molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
56. Latin America molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
57. Latin America molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
58. Latin America molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
59. Latin America molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
60. Brazil molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
61. Brazil molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
62. Brazil molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
63. Brazil molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
64. Rest of Latin America molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
65. Rest of Latin America molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
66. Rest of Latin America molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
67. Rest of Latin America molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
68. The Middle East and Africa molecular diagnostics market revenue, by product and services, 2024–2032 (USD Billion)
69. The Middle East and Africa molecular diagnostics market revenue, by application, 2024–2032 (USD Billion)
70. The Middle East and Africa molecular diagnostics market revenue, by technology, 2024–2032 (USD Billion)
71. The Middle East and Africa molecular diagnostics market revenue, by End-User, 2024–2032 (USD Billion)
Methodology
FrequentlyAsked Questions
Molecular diagnostics is a branch of laboratory medicine that analyzes biological markers in a patient's genome and proteome to diagnose and monitor disease. It involves studying DNA, RNA, and proteins to identify genetic mutations, infectious agents, and other abnormalities associated with diseases. This technology is crucial for early disease detection, personalized medicine, and treatment monitoring.
According to a study, the global molecular diagnostics market size was worth around USD 16.27 billion in 2023 and is expected to reach USD 44.03 billion by 2032.
The global molecular diagnostics market is expected to grow at a CAGR of 11.7% during the forecast period.
North America is expected to dominate the molecular diagnostics market over the forecast period.
Leading players in the global molecular diagnostics market include Becton Dickinson, Abbott Laboratories, Roche Diagnostics, Novartis, Johnson and Johnson, bioMerieux, Bio-Rad Laboratories, Qiagen NV, Siemens Healthcare, Danaher Corporation, and Hologic, among others.
The molecular diagnostics market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.
HappyClients
